Rotigotine
Rotigotine
Rotigotine (pronounced roh-TIG-oh-teen) is a dopamine agonist of the non-ergoline class of medications. It is used for the treatment of Parkinson's disease and Restless Legs Syndrome (RLS).
Etymology
The name "Rotigotine" is derived from its chemical structure. It is a derivative of the ergoline family of drugs, but unlike other ergolines, it does not contain the ergoline skeleton. Instead, it has a tetrahydroisoquinoline structure.
Usage
Rotigotine is used primarily for the treatment of early-stage Parkinson's disease and Restless Legs Syndrome. It works by stimulating dopamine receptors in the brain, which helps to improve symptoms of these conditions.
Side Effects
Common side effects of Rotigotine include nausea, vomiting, sleepiness, and dizziness. More serious side effects may include hallucinations, severe allergic reactions, and sudden sleep onset.
Related Terms
- Dopamine: A type of neurotransmitter, a chemical that helps transmit signals in the brain.
- Dopamine agonist: A class of drugs that activate dopamine receptors in the brain.
- Parkinson's disease: A long-term degenerative disorder of the nervous system that mainly affects the motor system.
- Restless Legs Syndrome: A condition characterized by an irresistible urge to move one's body to stop uncomfortable or odd sensations.
External links
- Medical encyclopedia article on Rotigotine
- Wikipedia's article - Rotigotine
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski